Inherited Disorders of Cholesterol Biosynthesis

Defects of cholesterol biosynthesis comprise a heterogeneous group of disorders, most of which have only been recently described and more are likely to follow in the near future.

Mevalonic aciduria (MVA) and hyperimmunoglobulinemia D syndrome (HIDS) are due to allelic defects in mevalonate kinase, an enzyme located proximally in the pathway of cholesterol and nonsterol isoprene biosynthesis. Clinically, patients affected with these disorders present with recurrent febrile attacks. This is the only manifestation in most patients with HIDS, and, in the case of classical mevalonic aciduria, is part of a severe multisystemic disease, including malformations, severe failure to thrive and neurological abnormalities. The other recognized defects of cholesterol biosynthesis are due to enzyme defects located distally in the pathway beyond the branching points of nonsterol isoprene biosynthesis and solely affecting cholesterol biosynthesis. Patients with these disorders all present with complex malformation syndromes involving different organ systems. The main characteristics of CHILD syndrome and Conradi-Huenermann syndrome are skeletal defects and ichthyosiform skin involvement. Smith-Lemli-Opitz syndrome and desmosterolosis are generalized malformation syndromes involving many different organs including the central nervous system.

The diagnosis of MVA and HIDS is based on determination of mevalonic acid in urine followed by determination of enzyme activity, whereas the search for the distally located defects of cholesterol biosynthesis requires sterol analysis in blood or tissues by GCMS.

Rational therapeutic approaches have been described for HIDS, MVA and Smith-Lemli-Opitz syndrome.

Key words

Cholesterol biosynthesis - Mevalonic aciduria - Hyperimmunoglobulinemia D syndrome - Smith-Lemli-Opitz syndrome - Conradi-Huenermann syndrome - CHILD syndrome

References

• 1 Abuelo D N, Tint G S, Kelley R I, Batta A K, Shefer S, Salen G. Prenatal detection of the cholesterol biosynthetic defect in the Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid sterols.  Am J Med Genet. 1995;  56 281-285
• 2 Andersson H C, Kratz L E, Kelley R I. Desmosterolosis presenting with multiple congenital anomalies and profound developmental delay.  J Inherit Metab Dis. 2000;  23 (Suppl. 1) 200
• 3 Braverman N, Lin P, Moebius F F, Obie C, Moser A, Glossmann H. et al . Mutations in the gene encoding 3β-hydroxysteroid-Δ7-Δ8-isomerase cause X-linked dominant Conradi-Huenermann syndrome.  Nature Genet. 1999;  22 291-294
• 4 Carr B R, Simpson E R. Cholesterol synthesis in human fetal tissues.  J Clin Endocrinol Metab. 1982;  55 447-452
• 5 Cooper M K, Porter J A, Young K A, Beachy P A. Plant derived and synthetic teratogens inhibit the ability of target tissues to respond to Sonic hedgehog signaling.  Science. 1998;  280 1603-1607
• 6 Cunniff C, Kratz L E, Moser A, Natowicz M R, Kelley R I. Clinical and biochemical spectrum of patients with RSH/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism.  Am J Med Genet. 1997;  68 263-269
• 7 Curry C J, Carey J C, Holland J S, Chopra D, Fineman R, Golabi M. et al . Smith-Lemli-Opitz syndrome type II: multiple congenital anomalies with male pseudohermaphroditism and frequent early lethality.  Am J Med Genet. 1987;  26 45-57
• 8 Derry J MJ, Gormally E, Means G D, Zhao W, Meindl A, Kelley R I. et al . Mutations in a Δ8-Δ7-sterol isomerase in the tattered mouse and X-linked dominant chondrodysplasia punctata.  Nature Genet. 1999;  22 286-290
• 9 Di Rocco M, Caruso U, Waterham H R, Picco P, Loy A, Wanders R JA. Mevalonate kinase deficiency in a child with periodic fever and without hyperimmunoglobulinemia D.  J Inherit Metab Dis. (in press); 
• 10 Drenth J PH, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser S D, de Jong J GN. et al . Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome.  Nature Genet. 1999;  22 178-181
• 11 Elias E R, Irons M B, Hurley A D, Tint G S, Salen G. Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS).  Am J Med Genet. 1997;  68 305-310
• 12 Fitzky B U, Witsch-Baumgartner M, Erdel M, Lee J N, Paik Y K, Glossmann H. et al . Mutations in the delta-7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome.  Proc Natl Acad Sci USA. 1998;  95 8181-8186
• 13 FitzPatrick D R, Keeling J W, Evans M J, Kan A E, Bell J E, Porteous M EM. Clinical phenotype of desmosterolosis.  Am J Med Genet. 1998;  75 145-152
• 14 Gibson K M, Hoffmann G F, Tanaka R D, Bishop R W, Chambliss K L. Mevalonate kinase map position 12 q24.  Chromosome Research. 1997;  5 150
• 15 Grange D K, Kratz L E, Braverman N E, Kelley R I. CHILD syndrome caused by deficiency of 3β-hydroxysteroid-Δ8, Δ7-isomerase.  Am J Med Genet. 2000;  90 328-335
• 16 Happle R. X-linked dominant chondrodysplasia punctata. Review of literature and report of a case.  Hum Genet. 1979;  53 65-73
• 17 Happle R, Koch H, Lenz W. The CHILD syndrome: Congenital hemidysplasia with ichthyosiform erythroderma and limb defects.  Eur J Ped Surg. 1980;  134 27-33
• 18 Happle R, Effendy I, Megahed M, Orlow S J, Kuster W. CHILD syndrome in a boy.  Am J Med Genet. 1996;  62 192-194
• 19 Hinson D D, Rogers Z R, Hoffmann G F, Schachtele M, Fingerhut R, Kohlschütter A. et al . Hematological abnormalities and cholestatic liver disease in two patients with mevalonate kinase deficiency.  Am J Med Genet. 1998;  78 408-412
• 20 Hinson D D, Ross R M, Krisans S, Shaw J L, Kozich V, Rolland M O. et al . Identification of a mutation cluster in mevalonate kinase deficiency, including one in a patient of mennonite ancestry.  Am J Hum Genet. 1999;  65 327-335
• 21 Hoffmann G F, Gibson K M, Brandt I K, Bader P I, Wappner R S, Sweetman L. Mevalonic aciduria: An inborn error of cholesterol and nonsterol isoprene biosynthesis.  N Engl J Med. 1986;  314 1610-1614
• 22 Hoffmann G F, Sweetman L, Bremer H J, Hunnemann D H, Hyanek J, Kozich V. et al . Facts and artefacts in mevalonic aciduria: development of a stable isotope dilution GCMS assay for mevalonic acid and its application to physiological fluids, tissue samples, prenatal diagnosis and carrier detection.  Clin Chim Acta. 1991;  198 209-228
• 23 Hoffmann G F, Charpentier C, Mayatepek E, Mancini J, Leichsenring M, Gibson K M. et al . Clinical and biochemical phenotype in eleven patients with mevalonic aciduria.  Pediatrics. 1993;  91 915-921
• 24 Houten S M, Kuis W, Duran M, de Koening T J, van Royen-Kerkhof A, Romeijn G J. et al . Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome.  Nature Genet. 1999;  22 175-177
• 25 Hübner C, Hoffmann G F, Charpentier C, Gibson K M, Finckh B, Puhl H, Lehr H A, Kohlschütter A. Decreased plasma ubiquinon-10 concentration in patients with mevalonic aciduria.  Ped Res. 1993;  34 129-133
• 26 Irons M, Elias R, Salen G, Tint G S, Batta A K. Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrom.  Lancet. 1993;  341 1414
• 27 Jira P E, Wevers R A, de Jong J, Rubio-Gozalbo E, Janssen-Zijlstra F SM, van Heyst A FJ. et al . Simvastatin: A new therapeutic approach for Smith-Lemli-Opitz syndrome.  J Lip Res. 2000;  41 1339-1346
• 28 Kelley R I. Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography/mass spectrometry of 7-dehydrocholestrol in plasma, amniotic fluid and cultured skin fibroblasts.  Clin Chim Acta. 1995;  236 45-58
• 29 Kelley R I, Roessler E, Hennekam R CM, Feldman G L, Kosaki K, Jones M C. et al . Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of sonic hedgehog?.  Am J Med Genet. 1996;  66 478-484
• 30 Kelley R I, Wilcox W G, Smith M, Kratz L E, Moser A, Rimoin D S. Abnormal sterol metabolism in patients with Conradi-Huenermann-Happle syndrome and sporadic lethal chondrodysplasia punctata.  Am J Med Genet. 1999;  83 213-219
• 31 Kelley R I. Inborn errors of cholesterol biosynthesis.  Adv Pediatr. 2000;  47 1-53
• 32 Koenig A, Happle R, Bornholdt D, Engel H, Grzeschik K H. Mutations in the NSDHL gene, encoding a 3β-hydroxysteroid dehydrogenase, cause CHILD syndrome.  Am J Med Genet. 2000;  90 339-346
• 33 Kratz L E, Kelley R I. Prenatal diagnosis of the RSH/Smith-Lemli-Opitz syndrome: prenatal diagnosis by quantification of cholesterol precursors in amniotic fluid.  Am J Med Genet. 1999;  82 376-381
• 34 Languis F AA, Waterham H R, Koster H, Dorland L, Duran M, de Konning T J. et al . Smith-Lemli-Opitz syndrome: the mild end of the clinical and biochemical spectrum.  J Inherit Metab Dis. 2000;  23 (Supp. 1) 196
• 35 Lin A E, Ardinger H H, Ardinger R H, Cunniff C, Kelley R I. Cardiovascular malformations in Smith-Lemli-Opitz syndrome.  Am J Med Genet. 1997;  68 270-278
• 36 Liu X Y, Dangel A W, Kelley R I, Zhao W, Denny P, Botcherby M. et al . The gene mutated in bare patches and striated mice encodes a novel 3 beta-hydroxysteroid dehydrogenase.  Nature Genet. 1999;  22 182-187
• 37 Lowry R B, Yong S L. Borderline normal intelligence in the Smith-Lemli-Opitz (RSH) syndrome.  Am J Med Genet. 1980;  5 137-143
• 38 Mayatepek E, Hoffmann G F, Bremer H J. Enhanced urinary excretion of leukotriene E4 in patients with mevalonate kinase deficiency.  J Pediatr. 1993;  123 96-98
• 39 Mills K, Mandel H, Montemagno R, Soothill P, Gershoni-Baruch R, Clayton P T. First trimester prenatal diagnosis of Smith-Lemli-Opitz syndrome (7-dehydrocholesterol reductase deficiency).  Pediatr Res. 1996;  39 816-819
• 40 Minsker D H, MacDonald J S, Robertson R T, Bokelman D L. Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.  Teratology. 1983;  28 449-456
• 41 Morell P, Jurevics H. Origin of cholesterol in myelin.  Neurochem Res. 1996;  21 463-467
• 42 Nwokoro N A, Wassif C A, Krakowiak P A, Kratz L E, Battaile K P, Steiner R D. et al . A genetic mouse model of Smith-Lemli-Opitz syndrome.  J Inherit Metab Dis. 2000;  23 (Suppl. 1) 198
• 43 Porter J A, Young K E, Beachy P A. Cholesterol modification of Hedgehog signalling proteins in animal development.  Science. 1996;  274 255-259
• 44 Roessler R, Belloni E, Gaudenz K, Jay P, Berta P, Scherer S W, Tsui L C, Muenke M. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly.  Nat Genet. 1996;  14(3) 257-360
• 45 Roux C, Aubry M M. Action tératogène chez le rat d'un inhibiteur de la synthèse du cholesterol, le AY 9944.  C R Soc Biol. 1966;  160 1353-1357
• 46 Ryan A K, Bartlett K, Clayton P, Eaton S, Mills L, Donnai D. et al . Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype.  J Med Genet. 1998;  35 558-565
• 47 Scarbrough P R, Huddleston K, Finley S C. An additional case of Smith-Lemli-Opitz syndrome in an 46 XY infant with female external genitalia.  J Med Genet. 1986;  23 174-175
• 48 Silve S, Dupuy P H, Labit-Leboteiller C, Kaghad M, Chalon P, Rahier A. et al . Emopamil-binding protein, a mammalian protein that binds a series of structurally diverse neuroprotective agents, exhibits delta8-delta7 sterol isomerase activity in yeast.  J Biol Chem. 1996;  217 22434-22440
• 49 Smith D W, Lemli L, Opitz J M. A newly recognized syndrome of multiple congenital anomalies.  J Pediatr. 1964;  64 210-217
• 50 Tint G S, Irons M, Elias E R, Batta A K, Frieden R, Chen T S. et al . Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome. N Engl J Med 194 330.  N Engl J Med. 1994;  322 107-113
• 51 Van der Meer J WM, Vossen J M, Radl J, Van Nieuwkoop J A, Meyer C JLM, Lobatto S. et al . Hyperimmunoglobulinemia D and periodic fever: A new syndrome.  Lancet. 1984;  1 1087-1090
• 52 Wassiff C A, Maslen C, Kachilele-Linjewile S, Lin D, Linck L M, Conner W E. et al . Mutations in the human sterol Δ7-reductase gene at 11 q12 - 13 cause Smith-Lemli-Opitz syndrome.  Am J Hum Genet. 1998;  63 55-62
• 53 Waterham H R, Wijburg F A, Hennekam R CM, Vreken P, Poll-The B T, Dorland L. et al . The Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene.  Am Hum Genet. 1998;  63 329-338
• 54 Witsch-Baumgartner M, Fitzky B U, Ogorelkova M, Kraft H G, Moebius F F, Glossmann H. et al . Mutational spectrum in the 7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome.  Am J Hum Genet. 2000;  66 402-412
• 55 Zizka J, Maresova J, Kerekes Z, Nozicka Z, Juttnerova V, Balicek P. Intestinal aganglionosis in the Smith-Lemli-Opitz syndrome.  Acta Paediatr Scand. 1983;  72 141-143